Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation.

Blood Adv · 2023 · PMC10500467 · PMID 37379285

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

showed a trendP = .057so close (0.05 < p ≤ 0.1)

Busulfan exposure < 59.5 mg × h/L showed a trend toward a higher risk of TRM than exposure ≥59.5 mg × h/L (HR, 0.5; 95% CI, 0.26-0.99; P = .057).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.